The level of miR-19b is upregulated by the activation of the EGFR/AKT pathway, which inhibits the apoptosis pathway in NSCLC cells via targeting Bcl2L11 and PPP2R5E, thereby promoting the proliferation of tumor cells [153]. The gene discussed is BCL2L11; the disease is neoplasm.